Pharmaceutical Lobbying Organization Begins " Go Boldly " Campaign

The high cost of drugs and the lobbying by pharmaceutical companies to generate public support for these high prices has been a topic of discussion for many months. The topic has also been a continuing focus of notes here onLab Soft News (see, for example:Researching the Cost of Stellara, a Drug Used to Treat Plaque Psoriasis;Pharma Money Flows into California Opposing Proposition 61;The Challenge of High Drug Prices in U.S.; Physicians' Use of Generics). Now comes news that the pharmceutical lobby, under fire for high drug prices, has launched a media campaign to combat negative opinions about the industry (see:Drug Lobby, Under Criticism, Starts Media Campaign). Below is an excerpt from the article:The largest lobbying organization for pharmaceutical companies began running TV ads...to improve the industry's image as criticism from U.S. President Donald Trump increases.The industry is touting developments in science by pharmaceutical companies and will spend"tens of millions" on television commercials....Pharmaceutical companies may be facing their most difficult time ahead as criticism about the price of drugs continues to increase.In a news conference this month, Trump said drug manufacturers were"getting away with murder" because of their pricing. Additionally, drug manufacturers were considered winners when the Affordable Care Act became law because more people had increased access to prescriptions. A...
Source: Lab Soft News - Category: Laboratory Medicine Authors: Tags: Cost of Healthcare Healthcare Business Medical Consumerism Medical Research Pharmaceutical Industry Source Type: blogs